Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. - Wikidata - awgldk - TriplyDB

Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.

Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.

http://www.wikidata.org/entity/Q35663498

about

Occlusion regulates epidermal cytokine production and inhibits scar formation Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas Critical role of NF-κB in pancreatic cancer TGFbeta in Cancer Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells Interleukin 1 alpha (IL1A) is a novel regulator of the blood-testis barrier in the rat Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome.Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta Chronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells.Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells.Roles of tumor suppressors in regulating tumor-associated inflammation.Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signaling Transforming growth factor-β2 and endotoxin interact to regulate homeostasis via interleukin-8 levels in the immature intestine.Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis NF-κB and cancer: a paradigm of Yin-Yang.Transcriptome-based identification of new anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions [corrected].Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium.Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.The TGF-beta paradox in human cancer: an update.The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids.NFkappaB mediates IL-1beta-induced down-regulation of TbetaRII through the modulation of Sp3 expression.Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.Use of forward genetics to discover novel regulators of NF-kappaB.Interleukins in glioblastoma pathophysiology: implications for therapy.Using the molecular classification of glioblastoma to inform personalized treatment.TGFβ: A player on multiple fronts in the tumor microenvironment.Interferon consensus sequence binding protein-induced cell proliferation is mediated by TGF-β signaling and p38 MAPK activation.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.IL-1β microenvironment promotes proliferation, migration, and invasion of human glioma cells.Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells.Phytoestrogen calycosin-7-O-β-D-glucopyranoside ameliorates advanced glycation end products-induced HUVEC damage.Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma.Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway.

P2860

Q24631725-5EECDD75-4876-439B-96D1-A9C245B47B62 Q24634265-2092B2E2-3461-4261-8525-110FAC9FAE4F Q24810414-24606EDF-8730-4D9F-9DF1-985802A204F5 Q26864198-569052E1-9EDB-4035-B64F-E30A06E3AD74 Q28288866-1ADF366B-3F3D-4D23-BDCF-31DDF18BAC1C Q28481277-BF6FB030-DF56-41E0-B376-19D31E8D8821 Q28571733-C81B89E1-24D6-419D-B9CE-1ECAEC6CB1FB Q33596681-52CDE7C1-813E-4606-A292-A293FE1A71B7 Q33673719-9D881F0D-668D-4562-8D34-BA1FBF6E85F0 Q33708065-2DAF78C0-CBB5-4CB3-8BF6-1F7B75B4D0B6 Q33936542-D0AA8C8E-2F65-47EA-B4DF-5D51082862D6 Q33968156-B2A43E30-53B3-479B-A3BF-F9F31C71A512 Q34238220-308935FA-679C-4A9C-930B-BA335FDC0580 Q34413441-6C4AF3DB-EE64-4600-AF15-F84186F6697B Q34606146-A53898F1-52AA-423B-BEEB-CECDBBA55ED9 Q34664048-09AEBCEC-D0D0-4D38-AB24-9432C3EBC16E Q35156109-F78A9FC8-019D-4570-9951-59E356C6EF95 Q35232248-7F93BE3A-C281-4960-ACBB-0D431D85815E Q35675344-E6830F02-ABBA-49EC-B31D-EB08C1EA4149 Q35955100-5ED8904B-20C3-4B12-A7F7-8875BF96A4D8 Q36982983-DDBC0B72-4073-4B79-8C2A-30507EB257DE Q36985163-BC476B56-8078-4DD0-9DC7-587946F4E2D3 Q37081881-2DED1D9D-6223-4B01-A316-409ED104F226 Q37261631-E61BDB7F-4E69-47D3-AF0A-C47BA9DC28DA Q37281661-E693207E-0B4C-4A96-A204-D4CA7242B62D Q37326107-3D4114AD-127E-4361-8DFD-68B4F1D2AA59 Q37414976-19AD3150-1AD5-4C5D-88C3-15C3BA5849A4 Q37568774-F35E1039-F49F-4DDF-9085-2E4E07867B7C Q37633861-7D033988-2ED9-44FF-A78A-B0E2B4710041 Q37762070-C5C38954-807B-4B04-96B0-1D2A3180925A Q38051761-BA628B8D-CE9D-432E-B800-E329980FFF2E Q38151582-65D81D48-CEA4-4B6C-AC53-787E737223F2 Q38241602-A50BD4F5-A110-4439-AD53-7D8449F19AC9 Q38334748-891E3D06-18E1-43A2-9F6A-1B6C0A0A900F Q38637324-3548E3B3-CA59-4630-9906-BFD8C81422F1 Q38972620-167620A4-586D-4DAB-AD8C-58D43EB6EEC5 Q39397148-CC973BEA-B478-433D-BE7B-286BD26DB1D0 Q39529329-2DF27097-4B6C-4069-B171-DC6C08BFE1E5 Q39652050-4532E431-801A-4836-8E30-BFF719D38CA5 Q39903905-C22F4CA5-0DA4-4702-BBAC-1C180A4E335B

P2860

Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.

http://www.wikidata.org/entity/Q35663498

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Dose-dependent cross-talk betw ...... erleukin-1 signaling pathways.

@ast

Dose-dependent cross-talk betw ...... erleukin-1 signaling pathways.

@en

type

label

Dose-dependent cross-talk betw ...... erleukin-1 signaling pathways.

@ast

Dose-dependent cross-talk betw ...... erleukin-1 signaling pathways.

@en

prefLabel

Dose-dependent cross-talk betw ...... erleukin-1 signaling pathways.

@ast

Dose-dependent cross-talk betw ...... erleukin-1 signaling pathways.

@en

P1433

Q35663498-028072C6-F930-46D6-AD9E-408AA7580ED3

P1476

Q35663498-C86E69DD-910C-466F-AC4B-EFBDE23DC680

P2093

Q35663498-1E2FAEC5-2A6D-4BC4-89DC-B41E89AE6731

Q35663498-25D52BD3-C41A-4FC6-8D42-09D310CE4BA5

Q35663498-802C9805-80CD-4B24-B323-DCF27A7E60CD

Q35663498-877D29B0-C6F2-4020-B326-C57107CDB34B

Q35663498-E52AF733-5C73-4C3D-B14C-972B801FDA16

P2860

Q35663498-0664B69F-0E78-43E1-B462-21C1DD41D897

Q35663498-0EE0A31D-CEE2-4CDF-9C8C-8DFB2678B5C3

Q35663498-1902E6C3-B960-4F2B-AB65-5E1DADBD3743

Q35663498-30D8BA79-002A-4F3C-A4F2-A5BACB9E9CF0

Q35663498-3986CC66-B549-4011-A1F3-50EAAE8548A4

Q35663498-4A2B97BD-99E9-4592-BC2C-C2D86B7D42BB

Q35663498-503193E9-C028-43D5-9124-FD8E65A0956A

Q35663498-68CA9B49-4F41-41EA-B446-EB44EBD19A1C

Q35663498-70F08631-DA3F-4DF1-B1D9-146470F83B51

Q35663498-784C06BB-81C7-4A9A-9D74-EBE9E6CF3F32

P304

Q35663498-9DBD7DBA-2816-4074-8106-312AACCA3EA8

P31

Q35663498-96E652C3-84F8-46EE-A302-2CF0393CE16F

P356

Q35663498-66A833A6-8AC7-4A58-B30D-8DD93F73E99D

P407

Q35663498-5219C663-03E4-4F06-B8EC-212E7C0484B5

P433

Q35663498-68CA3C1B-5975-4678-87DF-48D7B7868397

P478

Q35663498-4E47305B-AC75-4589-A82D-9050F29C8BB7

P577

Q35663498-86825435-9BE5-47EE-8D38-3CA309FB9850

P5875

Q35663498-9B158D1F-B5E2-4702-A837-FA165FA3AC0A

P698

Q35663498-D1A45042-FECA-4F7C-9801-DE80CDB6CBB9

P932

Q35663498-26C45809-DEE1-4BDB-BF77-11B17C9D8540

P356

PNAS.0700118104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Dose-dependent cross-talk betw ...... erleukin-1 signaling pathways.

@en

P2093

George R Stark

http://www.w3.org/2001/XMLSchema#string

Liping Tian

http://www.w3.org/2001/XMLSchema#string

Michael Vogelbaum

http://www.w3.org/2001/XMLSchema#string

Tao Lu

http://www.w3.org/2001/XMLSchema#string

Yulong Han

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol

Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein

Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression

BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6

The balance between IL-1 and IL-1Ra in disease

Signal transduction by the TGF-beta superfamily

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

TRAF6 is a signal transducer for interleukin-1

TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling

NF-kappaB at the crossroads of life and death

P304

4365-4370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0700118104

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6445770

http://www.w3.org/2001/XMLSchema#string

P698

17360530

http://www.w3.org/2001/XMLSchema#string

P932

1810327

http://www.w3.org/2001/XMLSchema#string